Project Grant R43AG097223
- This $399,999 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to further develop and test a novel, passive, and unobtrusive smartphone-based tool called SKYE for assessing cognitive function in peri- and post-menopausal women. The project has three key objectives: 1) cross-platform development of the SKYE tool, 2) testing the feasibility and usability of SKYE through focus groups, and 3) validating the SKYE cognitive score against gold-standard...
- This Project Grant award of $499,898 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of the "Zinnia All Day" mobile application by Zinnia Technologies Inc. The app aims to reduce caregiver stress and improve quality of life for persons living with Alzheimer's disease and related dementias (ADRD) by providing customizable video playlists to support daily routines and promote social engagement. The award period runs from September 2025 to...
- This federal Project Grant award of $441,612 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Trustees of Boston University (Boston University Medical Campus) supports research to evaluate the use of digital cognitive measures, such as digital pen tasks and voice recordings, to monitor early cognitive decline in relation to modifiable Alzheimer's disease risk factors. The project aims to leverage the Framingham Heart Study's longitudinal data on digital cognitive...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $499,396 to Bellage Inc. to develop the AWC-PRIME (Personalized Reinforcement Interface to Motivate Engagement) platform. The AWC-PRIME product builds upon Bellage's existing Adult Wellbeing Checkup (AWC) platform, extending it with a dynamic companion app to support care partners of people living with Alzheimer's disease and related dementias (ADRD). The app aims to help care partners...
- This $114,498 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study to investigate the construct validity of smartwatch-derived metrics for early detection of Alzheimer's disease and related dementias. The study will recruit a diverse sample of 90 participants aged 55 and older with healthy cognition or mild cognitive impairment from the Philadelphia region. Participants will wear a Garmin Vivosmart 4 smartwatch for 30 days to passively monitor...
- This Project Grant award of $326,382 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), is for the development and testing of "SEEINME" - a consumer-generated, HIPAA-compliant digital personal health profile for persons with dementia (PWD). The goal is to foster person-centered coordinated care and reduce caregiver burden by enabling assisted living/memory care communities to partner with and empower family members, informal...
- This $440,000 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development and validation of natural language processing tools for automated scoring of autobiographical memory interviews. The project aims to: Use advanced machine learning methods to improve the accuracy of the AI-powered memory scoring software, which has already shown strong agreement with manual scoring in preliminary validation. This will be achieved by fine-tuning large...
- The National Institute on Aging (NIA), through its Aging Research Federal Grant Program (CFDA 93.866), awarded a $499,778 project grant to S-3 Research LLC to co-design a mobile tool to improve diversity and inclusivity in Alzheimer's Disease and Related Dementias (ADRD) clinical trial participation. The project aims to leverage digital approaches, including mobile, website, and artificial intelligence chatbot features, to enhance the education, recruitment, and enrollment of older adults in...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $885,006 to Brigham & Women's Hospital Inc. to develop a smartphone-based point-of-care diagnostic system for detecting Alzheimer's disease-related biomarkers in blood plasma. The system will utilize microfluidics, nanotechnology, optical sensing, and deep learning to measure amyloid-beta, phosphorylated tau, and neurofilament light chain within 30 minutes, with the goal of creating an...
- This Project Grant award of $1,006,653 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Posit Science Corp. supports the "IMPROVING NEUROLOGICAL HEALTH WITH ACETYLCHOLINE VIA NEUROPLASTICITY-BASED COMPUTERIZED EXERCISE IN MILD COGNITIVE IMPAIRMENT (INHANCE-MCI)" program. The project aims to deploy a computerized cognitive training program that integrates validated exercises to potentially reduce the long-term risk of dementia onset in individuals with mild...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $499,686 to support the development of the Momento smartphone app. The app aims to transform regular photo activities into a way to continuously monitor cognitive function and detect early signs of memory changes in older adults. Key goals of the 1-year project include: 1) Testing how 200 older adults use and enjoy the app, ensuring it is engaging for regular use; and 2) Verifying the system can accurately assess brain health by comparing results to standard memory screening tests with 40 participants. The project is being conducted by the small business Dabble Health, Inc. (UEI: QQ51RLQDBHM6) and is expected to be completed by September 2026. If successful, the Momento app could provide a new standard for continuous brain health monitoring that avoids the anxiety and biases of traditional tests.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $499.7k | 9/18/25 |